The pharmaceutical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a promising development. Unlike subcutaneous injections, this technique offers a more convenient way to https://jimgpmr126355.bloggerchest.com/41097603/glp-1-patches-a-novel-approach-to-blood-sugar-control